Reduced Levels of Brain Derived Neurotrophic Factor (BDNF) in the Serum of Diabetic Retinopathy Patients and in the Retina of Diabetic Rats

Overview

Journal Cell Mol Neurobiol

Publisher Springer

Specialties Cell Biology
Molecular Biology
Neurology

Date 2012 Dec 29

PMID 23271640

Citations 47

Authors

M Shamsul Ola

Mohd Imtiaz Nawaz

Ahmed Abu El-Asrar

Marwan Abouammoh

Abdullah S Alhomida

Affiliations

Soon will be listed here.

Abstract

Diabetic retinopathy (DR) is widely recognized as a neurovascular disease. Retina, being a neuronal tissue of the eye, produces neurotrophic factors for its maintenance. However, diabetes dysregulates their levels and thereby may damage the retina. Among neurotrophins, brain derived neurotrophic factor (BDNF) is the most abundant in the retina. In this study, we investigated the level of BDNF in the serum of patients with DR and also in the serum and retina of streptozotocin-induced diabetic rats. The level of BDNF was significantly decreased in the serum of proliferative diabetic retinopathy patients as compared to that of non-diabetic healthy controls (25.5 ± 8.5-10.0 ± 8.1 ng/ml, p < 0.001) as well as compared to that of diabetic patients with no retinopathy (21.8 ± 4.7-10.0 ± 8.1 ng/ml, p < 0.001), as measured by ELISA techniques. The levels of BDNF in the serum and retina of diabetic rats were also significantly reduced compared to that of non-diabetic controls (p < 0.05). In addition, the expression level of tropomyosin-related kinase B (TrkB) was significantly decreased in diabetic rat retina compared to that of non-diabetic controls as determined by Western blotting technique. Caspase-3 activity was increased in diabetic rat retina after 3 weeks of diabetes and remained elevated until 10 weeks, which negatively correlated with the level of BDNF (r = -0.544, p = 0.013). Our results indicate that reduced levels of BDNF in diabetes may cause apoptosis and neurodegeneration early in diabetic retina, which may lead to neuro-vascular damage later in DR.

Citing Articles

Retinal and metabolic changes in a high-fat diet (HFD)+STZ model of Type II diabetes.

Phillips S, Feola A, Solomon J, Cardelle L, Douglass A, Bales K Mol Vis. 2025; 30:239-259.

PMID: 39959182 PMC: 11829795.

Serum Brain-Derived Neurotrophic Factor: An Emerging Marker for Diabetic Retinopathy.

K U V, Siddiqi S, Debbarman T, Mukherjee A, Akhtar N, Waris A Cureus. 2024; 16(11):e74153.

PMID: 39712817 PMC: 11663298. DOI: 10.7759/cureus.74153.

Low brain-derived neurotrophic factor and high vascular cell adhesion molecule-1 levels are associated with chronic kidney disease in patients with type 2 diabetes mellitus.

Chiang Y, Li Y, Chan Y, Cheng Y, Wu J, Lin J Front Endocrinol (Lausanne). 2024; 15:1403717.

PMID: 39355615 PMC: 11442372. DOI: 10.3389/fendo.2024.1403717.

Recent advances in the treatment and delivery system of diabetic retinopathy.

Wang Z, Zhang N, Lin P, Xing Y, Yang N Front Endocrinol (Lausanne). 2024; 15:1347864.

PMID: 38425757 PMC: 10902204. DOI: 10.3389/fendo.2024.1347864.

Brain-derived neurotrophic factor in diabetes mellitus: A systematic review and meta-analysis.

Moosaie F, Mohammadi S, Saghazadeh A, Dehghani Firouzabadi F, Rezaei N PLoS One. 2023; 18(2):e0268816.

PMID: 36787304 PMC: 9928073. DOI: 10.1371/journal.pone.0268816.

References

Xu Y, Ola M, Berkich D, Gardner T, Barber A, Palmieri F . Energy sources for glutamate neurotransmission in the retina: absence of the aspartate/glutamate carrier produces reliance on glycolysis in glia. J Neurochem. 2007; 101(1):120-31. DOI: 10.1111/j.1471-4159.2006.04349.x. View

Navaratna D, Guo S, Hayakawa K, Wang X, Gerhardinger C, Lo E . Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain. Diabetes. 2011; 60(6):1789-96. PMC: 3114398. DOI: 10.2337/db10-1371. View

Suchting S, Bicknell R, Eichmann A . Neuronal clues to vascular guidance. Exp Cell Res. 2005; 312(5):668-75. DOI: 10.1016/j.yexcr.2005.11.009. View

Suwa M, Kishimoto H, Nofuji Y, Nakano H, Sasaki H, Radak Z . Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus. Metabolism. 2006; 55(7):852-7. DOI: 10.1016/j.metabol.2006.02.012. View

Krabbe K, Nielsen A, Krogh-Madsen R, Plomgaard P, Rasmussen P, Erikstrup C . Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia. 2006; 50(2):431-8. DOI: 10.1007/s00125-006-0537-4. View

Eichmann A, Makinen T, Alitalo K . Neural guidance molecules regulate vascular remodeling and vessel navigation. Genes Dev. 2005; 19(9):1013-21. DOI: 10.1101/gad.1305405. View

Seki M, Tanaka T, Sakai Y, Fukuchi T, Abe H, Nawa H . Müller Cells as a source of brain-derived neurotrophic factor in the retina: noradrenaline upregulates brain-derived neurotrophic factor levels in cultured rat Müller cells. Neurochem Res. 2005; 30(9):1163-70. DOI: 10.1007/s11064-005-7936-7. View

Lom B, Cogen J, Sanchez A, Vu T, Cohen-Cory S . Local and target-derived brain-derived neurotrophic factor exert opposing effects on the dendritic arborization of retinal ganglion cells in vivo. J Neurosci. 2002; 22(17):7639-49. PMC: 6757994. View

Park K, Kim S, Kim J, Kim H, Im Y, Ahn C . Serum and tear levels of nerve growth factor in diabetic retinopathy patients. Am J Ophthalmol. 2008; 145(3):432-7. DOI: 10.1016/j.ajo.2007.11.011. View

10.

Mattson M, Maudsley S, Martin B . BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004; 27(10):589-94. DOI: 10.1016/j.tins.2004.08.001. View

11.

Seki M, Nawa H, Fukuchi T, Abe H, Takei N . BDNF is upregulated by postnatal development and visual experience: quantitative and immunohistochemical analyses of BDNF in the rat retina. Invest Ophthalmol Vis Sci. 2003; 44(7):3211-8. DOI: 10.1167/iovs.02-1089. View

12.

Abu-El-Asrar A, Dralands L, Missotten L, Al-Jadaan I, Geboes K . Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci. 2004; 45(8):2760-6. DOI: 10.1167/iovs.03-1392. View

13.

Liu X, Li Y, Liu Y, Luo Y, Wang D, Annex B . Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy. Am J Pathol. 2009; 176(1):504-15. PMC: 2797908. DOI: 10.2353/ajpath.2010.081152. View

14.

Yoshii A, Constantine-Paton M . Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol. 2010; 70(5):304-22. PMC: 2923204. DOI: 10.1002/dneu.20765. View

15.

Krady J, Basu A, Allen C, Xu Y, LaNoue K, Gardner T . Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes. 2005; 54(5):1559-65. DOI: 10.2337/diabetes.54.5.1559. View

16.

Grillo R, Ottoni G, Leke R, Souza D, Portela L, Lara D . Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. J Psychiatr Res. 2006; 41(1-2):31-5. DOI: 10.1016/j.jpsychires.2006.01.005. View

17.

Karege F, Schwald M, Cisse M . Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett. 2002; 328(3):261-4. DOI: 10.1016/s0304-3940(02)00529-3. View

18.

Nagahara A, Tuszynski M . Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov. 2011; 10(3):209-19. DOI: 10.1038/nrd3366. View

19.

Yamanaka M, Itakura Y, Ono-Kishino M, Tsuchida A, Nakagawa T, Taiji M . Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice. J Biosci Bioeng. 2008; 105(4):395-402. DOI: 10.1263/jbb.105.395. View

20.

Hallbook F, Backstrom A, Kullander K, Ebendal T, Carri N . Expression of neurotrophins and trk receptors in the avian retina. J Comp Neurol. 1996; 364(4):664-76. DOI: 10.1002/(SICI)1096-9861(19960122)364:4<664::AID-CNE5>3.0.CO;2-1. View